The authors describe a validation master plan for closed-vial filling technology.
Benoit Verjans
Advertisement
Articles by Benoit Verjans
The authors compare the exposure risk from viable particles from the air supply in four well-established aseptic filling technologies.
Advertisement
Latest Updated Articles
In-Depth Validation of Closed-Vial TechnologySeptember 1st 2012
Assessing Filling Technologies For Contamination RiskMarch 1st 2012
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
3
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
4
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
5